HOME >> MEDICINE >> NEWS
Cancer researchers confirm brain tumor genetic subtype informs treatment, predicts outcome

Calgary Research confirms that determining the genetic composition of brain cancers can better inform doctors and patients for treatment options and prognosis. The findings could change the future of how cancers are diagnosed.

A study published in the June issue of the Journal of Clinical Oncology confirmed that a specific chromosomal change in oligodendroglial brain tumours, first discovered by U of C researcher Dr. Gregory Cairncross, is associated with a very good prognosis and may also identify patients who would benefit from chemotherapy treatment in addition to radiotherapy at diagnosis for longer tumour control.

"The old school of thought was that a cancer is a cancer is a cancer, but that simply doesn't hold true with what we know today. Looking at a cancer under the microscope is not enough anymore," says Cairncross, principal investigator for the clinical trial and head of clinical neurosciences at the U of C's Faculty of Medicine and Calgary Health Region. "By testing for the genetic makeup of brain cancers, we can better define what 'cancer' we're dealing with, which helps us make better and wiser treatment recommendations for our patients."

This insight offers hope to refine the way brain cancers and all cancers are evaluated in the future. Recognizing the evolution from microscopic diagnosis to molecular diagnosis, the U of C and Alberta Cancer Board are developing a new Molecular Diagnostics Program in the Tom Baker Cancer Centre in Calgary, Alta. The program, which will provide space for testing the molecular and genetic composition of brain tumours, is initially funded by the Alberta Cancer Foundation Chair in Brain Tumour Research at the University of Calgary.

"The new laboratory will allow us to test the genetic makeup of brain cancers prior to starting treatment," says Dr. Chris Brown, director, of the Southern Alberta Cancer Research Institute. "Research is leading cancer researchers and clinicians t
'"/>

Contact: Colleen Donahue
colleen.donahue@ucalgary.ca
403-210-8522
Alberta Cancer Board
6-Jul-2006


Page: 1 2

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
8. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
9. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
10. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
11. Cancer-fighting foods, supplements explored in day-long symposium, March 25

Post Your Comments:
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, the ... to lead a national chief operating officer recruitment for Nicklaus Children’s ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/2/2015)... ... ... AvePoint Public Sector, Inc., a wholly owned subsidiary of ... it was named the recipient of the 2015 GTRA ConVurge Tech Award for Excellence ... Government Technology Research Alliance (GTRA), was presented June 29 during the ConVurge Honorary Awards ...
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected through ... they interact with products in their everyday lives. Technology can now help homeowners gain ... home entertainment and safety, as well as making kitchen tasks simpler. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... A Board ... CoolSculpting Plus, an advanced approach to body contouring. CoolSculpting Plus combines CoolSculpting® ... About the basic CoolSculpting procedure:, The CoolSculpting procedure is the only ...
(Date:7/2/2015)... ... July 02, 2015 , ... Denver-based SlimGenics Weight Control ... was named No. 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz ... been recognized. The award identifies outstanding woman-owned businesses that demonstrate excellence and success ...
Breaking Medicine News(10 mins):Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3
(Date:7/2/2015)... Conn. , July 2, 2015 Numotion,s ... Executive Officer announced that Tamas Feitel has ... Feitel joins Numotion after a highly successful 18 year ... leadership roles driving strategy, profitability, and productivity to result ... most recent position was Chief Financial Officer for GE ...
(Date:7/2/2015)... , July 2, 2015   Decision Resources ... retinal specialists identify less frequent dosing as the ... due to the burden on both patients and ... growth factor (VEGF) injections, which are the current ... abicipar pegol, which is in development for dosing ...
(Date:7/2/2015)... The report "Silage Inoculants & Enzymes Market ... Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & Geography - ... Enzymes Market is expected to reach $489.05 Million by ... 2020. Browse 75 market Tables and ... P ages and an in-depth TOC on ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
Cached News: